EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Models of Herpes Simplex Virus Latency

Paige N Canova iD, Audra J Charron iD, David A Leib iD

Viruses · 2024

DOI: 10.3390/v16050747 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, 2024. Verfasst von Paige N Canova und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA. Hauptthemen laut MEDLINE: Virus Latency, Herpes Simplex. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 243 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, NEI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Our current understanding of HSV latency is based on a variety of clinical observations, and in vivo, ex vivo, and in vitro model systems, each with unique advantages and drawbacks. The criteria for authentically modeling HSV latency include the ability to easily manipulate host genetics and biological pathways, as well as mimicking the immune response and viral pathogenesis in human infections. Although realistically modeling HSV latency is necessary when choosing a model, the cost, time requirement, ethical constraints, and reagent availability are also equally important. Presently, there remains a pressing need for in vivo models that more closely recapitulate human HSV infection. While the current in vivo, ex vivo, and in vitro models used to study HSV latency have limitations, they provide further insights that add to our understanding of latency. In vivo models have shed light on natural infection routes and the interplay between the host immune response and the virus during latency, while in vitro models have been invaluable in elucidating molecular pathways involved in latency. Below, we review the relative advantages and disadvantages of current HSV models and highlight insights gained through each.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Virus LatencyHerpes SimplexHumansAnimalsSimplexvirusHerpesvirus 1, HumanDisease Models, Animal

Stichwörter der Autor:innen

HSVin vivo and in vitro modelslatencyorganoidsreactivation

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA.
  • Guarini School of Graduate and Advanced Studies at Dartmouth, Hanover, NH 03755, USA.

ORCID-Profile: Paige N Canova, Audra J Charron, David A Leib

Förderung

  • NIH HHS
  • NIAID NIH HHS
  • NEI NIH HHS
  • National Institutes of Health

Zitieren

APA

Canova, P. N., Charron, A. J., & Leib, D. A. (2024). Models of Herpes Simplex Virus Latency. Viruses. https://doi.org/10.3390/v16050747

Vancouver

Canova PN, Charron AJ, Leib DA. Models of Herpes Simplex Virus Latency. Viruses. 2024. doi:10.3390/v16050747

BibTeX
@article{Canova2024,
  author = {Canova, Paige N and Charron, Audra J and Leib, David A},
  title = {Models of Herpes Simplex Virus Latency},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16050747}
}
Kostenlos starten →